drugset / Trial / NCT03422978

The Effects of Dexmedetomidine on Intravenous Anesthetic Requirements for Children Undergoing Dental Procedures

NCT03422978 ↗

Phase 4 Completed 88 enrolled University of British Columbia
RandomizedFactorialSingle-blindBasic science

Summary

The investigators propose to determine the propofol and remifentanil sparing effects of a single dose of dexmedetomidine in the dental population. The investigators plan to do this by performing a blinded study with 4 test groups (3 experimental and 1 control), using BIS monitoring to titrate TIVA infusion to an acceptable depth of anesthesia.

Timeline

Start
2018-03-14
Primary completion
2021-04-01
Completion
2021-04-01

Outcome

Met primary endpoint

paper The median [interquartile range] propofol infusion rate was lower in the 1 mcg/kg dexmedetomidine group (180 [164-185] mcg/kg/min) versus placebo (200 [178-220] mcg/kg/min): PMID 39193655 ↗

paper p = 0.013. PMID 39193655 ↗

paper The remifentanil infusion rate was also lower in the 1 mcg/kg dexmedetomidine group (0.089 [0.080, 0.095] mcg/kg/min) versus placebo (0.103 [0.095, 0.106] PMID 39193655 ↗

paper p = .022. PMID 39193655 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.25 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 1 ug/kg Intravenous

Indications

No indication recorded.